Skip to main content
Premium Trial:

Request an Annual Quote

Peter Leddy, Nassim Usman, J Michael French, Open Biosystems


People in the News

Invitrogen said last month that Peter Leddy has joined the company as senior vice president of human resources.

In this role, Leddy will oversee Invitrogen's global HR strategy and "lead all aspects of human resources, including talent acquisition, employee development, internal communications, compensation and benefits, and acquisition integration," the company said.

Leddy most recently served as vice president of human resources for the Americas operations of Dell. Prior to joining Dell, Leddy was executive vice president of human resources at Promus Hotel. He holds a PhD and MS in industrial organization psychology from the Illinois Institute of Technology, according to Invitrogen.

Nassim Usman has been named entrepreneur-in-residence, focusing on investment opportunities in biotechnology, at Morgenthaler Ventures.

Previously, Usman served as senior vice president and COO of Sirna Therapeutics. Prior to this, he was CSO at Sirna, as well as its previous incarnation, Ribozyme Pharmaceuticals. He has also served on the board of directors at Archemix and Atugen.

Usman holds a BSc and PhD in chemistry from McGill University.

Sirna Therapeutics said this week that it has named J Michael French as senior vice president for corporate development.

n this role, French will "lead Sirna's corporate development activities, including partnerships, collaborations, product licensing, and mergers and acquisitions," the company said.

Previously, French was CBO at Entelos, where he was responsible for business development, alliance management, and corporate communication activities, Sirna said. Before this, he helped develop global strategic alliances for Farma Biagini.

French holds a BS in aerospace engineering from the US Military Academy at West Point, as well as an MS in physiology and biophysics from Georgetown University, according to Sirna.


Products & Services

Open Biosystems has recently introduced the Expression Arrest/RNAi Consortium shRNA libraries.

Open Biosystems' deal with the RNAi Consortium to sell the libraries was first reported in RNAi News in May (see RNAi News, 5/13/2005).

According to Open Siosystems, the library currently consists of 47,500 shRNA constructs covering 9,500 human and mouse genes, and will continue to be expanded on a quarterly basis until all 150,000 constructs are completed.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.